FDA issues guidance on clinical trial rules compliance

08/29/2013 | PharmaTimes (U.K.) · Clinica (subscription required)

Guidance aimed at making sure that drug and medical device trials present limited risk to patients and satisfy regulations has been released by the FDA. The guidance outlines how institutional review boards should assess qualifications of researchers and the fitness of trial sites.

View Full Article in:

PharmaTimes (U.K.) · Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ